Investigational Drug Information for Mephedrone
✉ Email this page to a colleague
What is the development status for investigational drug Mephedrone?
Mephedrone is an investigational drug.
There have been 4 clinical trials for Mephedrone.
The most recent clinical trial was a Phase 1 trial, which was initiated on January 30th 2020.
The most common disease conditions in clinical trials are Amphetamine-Related Disorders, Substance-Related Disorders, and Disease. The leading clinical trial sponsors are Instituto de Salud Carlos III, Parc de Salut Mar, and Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia.
There are twenty-seven US patents protecting this investigational drug and five hundred and sixteen international patents.
Summary for Mephedrone
| US Patents | 27 |
| International Patents | 516 |
| US Patent Applications | 218 |
| WIPO Patent Applications | 229 |
| Japanese Patent Applications | 166 |
| Clinical Trial Progress | Phase 1 (2020-01-30) |
| Vendors | 11 |
Recent Clinical Trials for Mephedrone
| Title | Sponsor | Phase |
|---|---|---|
| Abuse Potential and Human Pharmacology of Methylone | Fundació Recerca Institut Germans Trias i Pujol | Phase 1 |
| Abuse Potential and Human Pharmacology of Methylone | Istituto Superiore di Sanità | Phase 1 |
| Abuse Potential and Human Pharmacology of Methylone | Germans Trias i Pujol Hospital | Phase 1 |
Clinical Trial Summary for Mephedrone
Top disease conditions for Mephedrone
Top clinical trial sponsors for Mephedrone
US Patents for Mephedrone
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Mephedrone | ⤷ Sign Up | Compositions and methods for treating psychiatric disorders | GOSFORTH CENTRE (HOLDINGS) PTY LTD. (Maroochydore, Queensland, AU) | ⤷ Sign Up |
| Mephedrone | ⤷ Sign Up | Bile acid receptor agonism for treating addiction | Vanderbilt University (Nashville, TN) | ⤷ Sign Up |
| Mephedrone | ⤷ Sign Up | Topical compositions and methods of treatment of topical disorders | PeriTech Pharma Ltd. (Herzliya, IL) | ⤷ Sign Up |
| Mephedrone | ⤷ Sign Up | Topical compositions and methods of treatment of anorectal disorders | PeriTech Pharma Ltd. (Herzilya, IL) | ⤷ Sign Up |
| Mephedrone | ⤷ Sign Up | Small molecule agonists of neurotensin receptor 1 | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (La Jolla, CA) | ⤷ Sign Up |
| Mephedrone | ⤷ Sign Up | Preparation of desiccated liposomes for use in compressible delivery systems | SMARTEK INTERNATIONAL LLC (Livingston, NJ) | ⤷ Sign Up |
| Mephedrone | ⤷ Sign Up | Triazole agonists of the APJ receptor | AMGEN INC. (Thousand Oaks, CA) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Mephedrone
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Mephedrone | European Patent Office | EP2812438 | 2032-01-09 | ⤷ Sign Up |
| Mephedrone | World Intellectual Property Organization (WIPO) | WO2013106464 | 2032-01-09 | ⤷ Sign Up |
| Mephedrone | World Intellectual Property Organization (WIPO) | WO2017087278 | 2032-01-09 | ⤷ Sign Up |
| Mephedrone | Australia | AU2009279372 | 2028-08-06 | ⤷ Sign Up |
| Mephedrone | Canada | CA2732131 | 2028-08-06 | ⤷ Sign Up |
| Mephedrone | China | CN102170874 | 2028-08-06 | ⤷ Sign Up |
| Mephedrone | European Patent Office | EP2331088 | 2028-08-06 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
